Institutional Ownership Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN). We have compiled data on the 11 institutions that hold shares in the stock, with a total of 277,925 shares, which have been reported (via 13F filing form) to have a value of $272,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
95,375
shares
|
$93,467
0.0% of portfolio
|
Q3 2025
Added 91.04%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
66,400
shares
|
$65,072
0.0% of portfolio
|
Q3 2025
Reduced 16.9%
|
|
|
Meitav Dash Investments LTD
|
Oct 29, 2025 Q3 2025 |
40,000
shares
|
$39,200
0.0% of portfolio
|
Q2 2024
Reduced 20.0%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
21,086
shares
|
$20,664
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Commonwealth Equity Services, LLC
|
Oct 22, 2025 Q3 2025 |
21,080
shares
|
$20,658
0.0% of portfolio
|
Q2 2025
Added 22.2%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
15,870
shares
|
$15,552
0.0% of portfolio
|
Q4 2024
Added 32.66%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
14,659
shares
|
$14,365
0.0% of portfolio
|
Q3 2025
Added 809.93%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Nov 04, 2025 Q3 2025 |
1,455
shares
|
$1,425
0.0% of portfolio
|
Q3 2025
Reduced 67.34%
|
|
|
Jones Financial Companies Lllp
|
Nov 04, 2025 Q3 2025 |
1,000
shares
|
$980
0.0% of portfolio
|
Q3 2025
Reduced 90.84%
|
|
|
Cwm, LLC
|
Oct 15, 2025 Q3 2025 |
1,000
shares
|
$980
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|